Skip to main content
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc. · Share Buybacks

Track LCTX — free
$0.77 -0.05 (-5.87%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$195.26M
Shares
252.95M
Volume · Nov 20 2.04M Avg daily vol (3M) 1.63M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-03-22 $60,000,000 $55,400,000 as of 2026-09-30 —
Key facts CIK 876343 CUSIP 53566P109 13F (30d) 146 filings 122 filers Visit website Investor relations